首页> 外文OA文献 >FRI0591 RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH TREATMENT WITH IMMUNE CHECKPOINT INHIBITORS: A CASE SERIES FROM TWO REFERRAL CENTRES

【2h】

FRI0591 RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH TREATMENT WITH IMMUNE CHECKPOINT INHIBITORS: A CASE SERIES FROM TWO REFERRAL CENTRES

机译：Fri0591与免疫检查点抑制剂治疗相关的风湿性免疫相关不良事件：来自两个推荐中心的案例系列

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Sebastian C. Rodriguez-García; David Lobo; Raul Castellanos-Moreira; Millán Arciniegas Ana Milena; Roberto Gumucio; Ana Laiz; Virginia Ruiz-Esquide; Berta Magallares; Cesar Díaz-Torné; Patricia Moya; Ivan Castellví; Hector Corominas; Jose A. Gómez-Puerta;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis [J] . Sophia H. Verspohl, Tobias Holderried, Charlotte Behning, Therapeutic advances in musculoskeletal disease. . 2021,第a期

机译：免疫检查点抑制作用后风湿免疫相关不良事件患者的患病率，治疗和肿瘤反应：单中心分析
2. Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis [J] . Shuo Zhang, Ziyue Zhou, Li Wang, Therapeutic advances in chronic disease. . 2021,第a期

机译：与免疫检查点抑制剂相关的风湿性免疫相关不良事件与肿瘤患者的安慰剂相比：系统性评论和荟萃分析
3. Correction: Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity [J] . RMD Open . 2017,第2期

机译：更正：癌症检查点治疗的风湿免疫相关不良事件：一种新的疾病学实体案例系列
4. Identification of Patients with Immune-related Adverse Events from Clinical Notes using Machine Learning [C] . Samir Gupta, Anas Belouali, Neil Shah, IEEE International Conference on Healthcare Informatics . 2020

机译：使用机器学习鉴定免疫相关不良事件的患者
5. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
6. Prevalence therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis [O] . Sophia H. Verspohl, Tobias Holderried, Charlotte Behning, 2021

机译：免疫检查点抑制作用后风湿免疫相关不良事件患者的患病率治疗和肿瘤反应：单中心分析
7. POS1341 TOCILIZUMAB FOR THE TREATMENT OF IMMUNE-RELATED ADVERSE EVENTS TO IMMUNE CHECKPOINT INHIBITORS: A CASE SERIES [O] . C. Campochiaro, N. Farina, A. Tomelleri, 2021

机译：POS1341对免疫检查点抑制剂的免疫相关不良事件进行治疗：案例系列

FRI0591 RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH TREATMENT WITH IMMUNE CHECKPOINT INHIBITORS: A CASE SERIES FROM TWO REFERRAL CENTRES

著录项

相似文献

相关主题

期刊订阅